FMS-related tyrosine kinase-3 (FLT3) mutations have also been identified in cases with AML associated with SS [18,70] in approximately 39% of patients, and FLT-3 inhibitors are a known SS inducer [13]. This evidence concerns the gene FLT3 and acute myeloid leukemia.